|
|
"Enhancement of Brain Tumor Immunotherapy by Fas-L RNAi"
|
4R33CA112148-03
|
$348,323
|
$348,323
|
Olivi, Alessandro
|
JOHNS HOPKINS UNIVERSITY
|
|
|
"Regulation of Glioma Cell Apoptosis in PKCDelta"
|
5R01CA109196-04
|
$242,696
|
$242,696
|
BRODIE, CHAYA
|
HENRY FORD HEALTH SYSTEM
|
|
|
4-Demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) Phase I Clinical Tr
|
1R43CA132257-01A1
|
$140,983
|
$140,983
|
MORGAN, Lee
|
DEKK-TEC, INC.
|
|
|
A Diffusion-Based MRI Method to Detect Glioma Invasion
|
5R21CA109280-02
|
$151,500
|
$151,500
|
SCHMAINDA, KATHLEEN
|
MEDICAL COLLEGE OF WISCONSIN
|
|
|
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent or
|
Z01 BC 010585
|
$23,122
|
$13,873
|
Warren, Katherine
|
CCR (NCI)
|
|
|
A pilot study of statin therapy and risk of malignant glioma
|
1K07CA127468-01A1
|
$135,513
|
$135,513
|
Lai, Rose
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
AARP prospective study of diet and cancer
|
Z01 CP010196-03152
|
$2,416,410
|
$120,820
|
Schatzkin, Arthur
|
DCEG (NCI)
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S1
|
$104,604
|
$4,184
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-33S2
|
$250,000
|
$10,000
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-33
|
$7,326,647
|
$293,066
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Advanced Training in Surgical Oncology
|
5T32CA009535-23
|
$327,432
|
$65,486
|
IGLEHART, JAMES
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
ALARA Meeting
|
Z01 CP010131-10444
|
$19,805
|
$6,932
|
Ron, Elaine
|
DCEG (NCI)
|
|
|
Allergic Condition Susceptibility Polymorphisms and Glioma Risk
|
1R01CA122163-01A2
|
$544,169
|
$544,169
|
SCHWARTZBAUM, JUDITH
|
OHIO STATE UNIVERSITY
|
|
|
Allergies, Genetic Susceptibility and Adult Glioma Risk
|
7R01CA114205-03
|
$371,078
|
$371,078
|
MICHAUD, DOMINIQUE
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
|
|
Allogeneic glioma vaccine using TGF-beta knockouts
|
5R44CA105964-03
|
$808,783
|
$808,783
|
FAKHRAI, HABIB
|
NOVARX CORPORATION
|
|
|
American College of Radiology Imaging Network
|
2U01CA080098-10
|
$9,101,961
|
$455,098
|
Schnall, Mitchell
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
Z01 BC 010709
|
$92,488
|
$83,239
|
Warren, Katherine
|
CCR (NCI)
|
|
|
An investigation of radial glia as the source of ependymoma stem cells
|
5R01CA129541-02
|
$318,725
|
$318,725
|
Gilbertson, Richard
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
|
|
Analysis of the p53 in vivo using a unique mouse model
|
2R01CA100193-06
|
$335,365
|
$67,073
|
EVAN, GERARD
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Angiopoietin-2 and Glioma Invasion
|
5R01CA102011-05
|
$288,651
|
$288,651
|
CHENG, SHI-YUAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Ape1, oxidative stress and glioma alkylator resistance
|
5R01CA104593-05
|
$283,597
|
$283,597
|
SILBER, JOHN
|
UNIVERSITY OF WASHINGTON
|
|
|
Astatine and Iodine Radiolabeled Monoclonal Antibodies
|
5R37CA042324-23
|
$448,748
|
$224,374
|
ZALUTSKY, MICHAEL
|
DUKE UNIVERSITY
|
|
|
Astrocytic Cancers: How, When, Where?
|
5U01CA084314-10
|
$976,583
|
$976,583
|
VAN DYKE, TERRY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
|
Atlanta Regional Community Clinical Oncology Program (ARCCOP)
|
2U10CA045450-22
|
$761,812
|
$7,618
|
SEAY, THOMAS
|
ST. JOSEPH'S HOSPITAL
|
|
|
Autophagy inhibition as a therapeutic strategy for glioblastoma mutliforme
|
1R21CA133898-01
|
$369,053
|
$369,053
|
AMARAVADI, RAVI
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
AZD2171 and chemoradiation for newly diagnosed glioblastoma
|
5R01CA129371-02
|
$583,728
|
$583,728
|
Batchelor, Tracy
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
Z01 BC 010856
|
$12,323,380
|
$1,232,338
|
Custer, Mary
|
CCR (NCI)
|
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-19
|
$481,201
|
$4,812
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
|
Bcl-2 family proteins in the ER-mediated apoptosis
|
5K01CA098092-05
|
$124,308
|
$62,154
|
ZONG, WEI-XING
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-07
|
$1,049,588
|
$10,496
|
DECKER, DAVID
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
|
bHLH Factors in Medulloblastoma Genesis and Maintenance
|
5R01CA112350-04
|
$310,300
|
$310,300
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
BIDMC Research Training Grant in Cancer Radiology
|
5T32CA059367-14
|
$139,719
|
$27,944
|
CLOUSE, MELVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Biomarkers of survival in glioma epidemiology
|
1R01CA126831-01A2
|
$416,687
|
$416,687
|
Wiencke, John
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Biomodulation of anticancer drugs targeting DNA
|
5R01CA116491-02
|
$228,000
|
$75,240
|
CARRIER, FRANCE
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
BIOSYNTHETIC KEY STEPS OF ANGUCYCLINE ANTITUMOR DRUGS
|
5R01CA102102-04
|
$246,853
|
$49,371
|
ROHR, JURGEN
|
UNIVERSITY OF KENTUCKY
|
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
5R01CA115745-03
|
$335,708
|
$335,708
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
|
Bone Lead and Brain Cancer
|
Z01 CP010132-10407
|
$6,350
|
$6,350
|
Linet, Martha
|
DCEG (NCI)
|
|
|
Bone Marrow Stem Cells: Novel Treatment of Human Glioma
|
5R01CA115729-03
|
$265,423
|
$265,423
|
LANG, FREDERICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Brain cancer in Eastern Nebraska case-control study
|
Z01 CP010119-02210
|
$12,528
|
$12,528
|
Alavanja, Michael
|
DCEG (NCI)
|
|
|
Brain Neoplasia and Multiple Quantum Sodium MRI
|
5R01CA106840-04
|
$278,090
|
$278,090
|
BOADA, FERNANDO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Brain tumor angiogenesis: Integrin ceramide signaling
|
5R01CA098568-05
|
$266,432
|
$266,432
|
ERDREICH-EPSTEIN, ANAT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
|
|
Brain Tumor Animal Therapeutics Core
|
Z01 BC 011086
|
$769,374
|
$769,374
|
Fine, Howard
|
CCR (NCI)
|
|
|
Brain Tumor Clinical and Clinical Research Program
|
Z01 BC 011098
|
$1,538,748
|
$1,230,999
|
Fine, Howard
|
CCR (NCI)
|
|
|
Brain tumor family study of genetic susceptibility and environmental factors
|
Z01 CP005803-08050
|
$5,408
|
$2,434
|
Goldstein, Alisa
|
DCEG (NCI)
|
|
|
BRAIN TUMOR SPORE GRANT
|
5P50CA097257-07
|
$2,327,870
|
$2,327,870
|
BERGER, MITCHEL
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
|
|
Brain Tumor Therapeutic Efficacy by Quantitative MR
|
5P01CA085878-06
|
$2,437,189
|
$2,437,189
|
Ross, Brian
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Brain Tumors - Immunological and Biological Studies
|
4R37CA011898-38
|
$670,357
|
$670,357
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S5
|
$4,587,184
|
$458,718
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Cancer Center Core Support Grant
|
3P30CA016042-33S6
|
$113,837
|
$11,384
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
Cancer Center Core Support Grant
|
3P30CA016086-33S1
|
$90,929
|
$5,456
|
EARP, H
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
Total relevant funding to Brain for this search: $137,013,491
|
